Bidirectional relationships between sleep and amyloid-beta in the hippocampus

https://doi.org/10.1016/j.nlm.2018.06.009Get rights and content

Highlights

  • Hippocampal Aß pathology is linked to changes in wake/sleep duration.

  • Hippocampal Aß pathology also associates with changes in wake/sleep quality.

  • Sleep disturbances reciprocally impact Aß pathology in the hippocampus.

  • Future research should assess mechanisms and specificity of these relationships.

Abstract

Alzheimer’s disease (AD) is a debilitating neurodegenerative disease characterized by progressive hippocampal-dependent explicit memory deficits that begin at the onset of the illness. An early hallmark of AD is the accumulation of amyloid-beta (Aß) proteins in brain structures involved in encoding and consolidation of memory, like the hippocampus and prefrontal cortex. Aß neurotoxicity is known to induce synaptic dysfunctions and neuronal death leading to cognitive decline. Another recurrent event observed in AD is sleep disturbances. Decreased sleep duration, sleep fragmentation, and circadian alterations are often observed in early AD. The origin of these disturbances, and especially the specific contribution of the hippocampal Aß pathology, remains to be determined. It is required to identify mechanisms impacting wakefulness and sleep architecture and microarchitecture given the role of sleep in memory encoding and consolidation. Sleep perturbations in AD are thus likely contributing to memory decline in the course of the disease. The central aim of this review is to address the bidirectional relationship between sleep and hippocampal Aß by discussing the literature featuring data on wakefulness and sleep variables (i.e., duration, electroencephalographic activity, daily distribution) in AD mouse models and on the effect of enforced sleep loss on Aß pathology in the hippocampus. The current state of knowledge on this topic emphasizes a clear need for more efforts to assess the precise impact of hippocampal Aß on wakefulness and sleep quality as well as the mechanisms mediating their reciprocal relationship.

Introduction

Alzheimer’s disease (AD) is the most common form of dementia among people over 65-years old, and affects around one in three individuals over 85-years (Ferri et al., 2005, Lautenschlager et al., 1996). The earliest clinical symptom of this age-related neurodegenerative disorder is decline in hippocampal-dependent explicit memory (memory for facts and events) (Braak and Braak, 1991, Lambon Ralph et al., 2003, Welsh et al., 1992). One of the most studied neuropathological hallmarks of AD is the accumulation of amyloid-beta (Aβ) proteins which begins approximately 10–15 years before clinical symptoms become apparent (Holtzman et al., 2011, Murphy and LeVine, 2010, Sadigh-Eteghad et al., 2015, Sperling et al., 2011). This protein origins from a cleavage of the amyloid precursor protein (APP) and tends to oligomerize rapidly into soluble amyloid-beta oligomers (Aßo) to eventually form insoluble fibrils and senile plaques (Findeis, 2007). Soluble Aβo were shown to be the most toxic form of the protein and to induce synaptic dysfunction, neuronal death, and cognitive deficits by molecular mechanisms that still need to be fully established (Brouillette, 2014, Ma and Klann, 2012).

Another hallmark that is being increasingly investigated in AD patients is disturbance in sleep and circadian rhythms. Cognitive decline in early AD was indeed shown to be accompanied by difficulty to induce and maintain sleep, shifts in sleep/wake pattern, reduction in rapid eye movement (REM) sleep, and circadian alterations (Peter-Derex et al., 2015, Petit et al., 2004). It seems particularly important to understand the origin of these sleep disturbances in AD given that there is a large body of evidence showing a marked influence of the different sleep stages on hippocampus-dependent memory processes. For example, slow wave oscillations observed during non-REM (NREM) sleep are crucial for memory consolidation after learning a spatial task (Diekelmann & Born, 2010). Furthermore, REM sleep, characterized by electroencephalographic (EEG) theta (4–9 Hz) activity, has been shown to have roles in spatial and contextual memory consolidation (Boyce, Glasgow, Williams, & Adamantidis, 2016). The hippocampus is also involved in the generation of sleep oscillations related to memory processes, such as NREM sleep sharp wave ripples and REM sleep theta activity (Nokia et al., 2012, Boyce et al., 2016).

In view of that, sleep deprivation (SD) in rodents and humans is known to have deleterious impacts on learning and memory consolidation. For instance, deprivation of REM sleep in mice has been shown to induce deficits in hippocampus-dependent memory consolidation (Chen, Tian, & Ke, 2014), without affecting hippocampus-independent memory (Rasch, Pommer, Diekelmann, & Born, 2009). Also, there is considerable evidence that the hippocampus is strongly affected by SD. In fact, SD impacts hippocampal volume, plasticity and memory processing leading to memory deficits (Kreutzmann et al., 2015, Havekes and Abel, 2017). The inter-dependency between hippocampal and sleep functions including the susceptibility of this brain region to sleep loss could exacerbate vulnerability to other disturbing factors, such as the accumulation of toxic Aßo in AD.

Two main topics will be addressed in this review. First, we will examine the growing body of evidence indicating that accumulation of Aß in the hippocampus has an impact on wakefulness/sleep duration, consolidation and fragmentation, electroencephalographic (EEG) activity, as well as daily distribution. The main evidences are based on studies using transgenic AD mouse models, in which the production and accumulation of Aß are modified in the hippocampus (Table 1 lists the main characteristics of five of these AD models), and from complementary human studies. Sleep features of animal models injected with Aβ directly in the hippocampus will also be reviewed, although it should be noted that literature using this type of model is less abundant than studies using transgenic mice. Second, we will review the literature focusing on how sleep disturbance or deprivation can reciprocally affect Aß pathology in the hippocampus.

Section snippets

Wake/sleep duration and consolidation

A first sleep variable that seems to be consistently affected by higher hippocampal Aß level is the duration of wakefulness and sleep. More precisely, an increase in wakefulness has been observed in different transgenic mouse models showing Aß accumulation in the hippocampus and cerebral cortex. The PLB1 triple transgenic AD mouse model, which displays a modest plaque load in the hippocampus (Table 1), showed longer wakefulness duration at both 5 and 12 months (mo) of age, and an increase in the

Effects of sleep disturbances on hippocampal Aß

The bidirectional relationship between Aß and sleep will be considered here by emphasizing the impact of sleep disturbances on Aß in the hippocampus. This is relevant because an increasing number of studies demonstrate that sleep disruptions occur at the very onset of AD or even the prodromal phase (Musiek et al., 2013). Therefore, sleep disturbances may affect and even accelerate Aß pathology in the pre-symptomatic phases of the disease. One of the most used and efficient way to test this

Effects of sleep disturbances on Aß-driven neuropathology

SD/SR may not only affect the level of Aß in the hippocampus, but also Aß-driven inflammation and neurodegeneration even in the absence of a direct effect on Aß. It is well established that SD enhances the inflammatory state of the brain by acting on cytokines, other pro-inflammatory markers, and by activating glial cells (Clinton et al., 2011, Havekes et al., 2012, Irwin et al., 2016, Krueger et al., 2001). Given the susceptibility of the hippocampus to SD (Kreutzmann et al., 2015), a higher

Conclusion and perspectives

This review first illustrated that the presence of Aß in the hippocampus is associated with a diversity of sleep disturbances in AD mouse models (Fig. 1). A main phenotype conserved in most models is an increase in wake duration and a decrease in sleep duration affecting, in general, both NREM and REM sleep stages. Wakefulness and sleep quality was also reported to be affected in most animal models that showed vigilance state fragmentation and many modifications of EEG activity. Finally, the

Acknowledgments

We thank Jamie Simon of Salk Institute for Biological Studies for the background image of Fig. 1.

Financial support

JDG is supported by a J.A. De Sève fellowship from the Centre de Recherche de l’Hôpital du Sacré-Coeur de Montréal. VM is supported by the Canada Research Chair in Sleep Molecular Physiology and a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC). JB is supported by a salary award and a grant from the Fonds de recherche du Québec – Santé (FRQS) and a grant from NSERC.

Conflict of interest

The authors declare no conflict of interest.

References (111)

  • R. Havekes et al.

    The tired hippocampus: The molecular impact of sleep deprivation on hippocampal function

    Current Opinion in Neurobiology

    (2017)
  • R. Havekes et al.

    The impact of sleep deprivation on neuronal and glial signaling pathways important for memory and synaptic plasticity

    Cellular Signalling

    (2012)
  • D. Hermann et al.

    Synaptic transmission is impaired prior to plaque formation in amyloid precursor protein-overexpressing mice without altering behaviorally-correlated sharp wave-ripple complexes

    Neuroscience

    (2009)
  • J. Holth et al.

    Sleep in Alzheimer's disease - Beyond amyloid

    Neurobiology of Sleep and Circadian Rhythms

    (2017)
  • M.R. Irwin et al.

    Sleep disturbance, sleep duration, and inflammation: A systematic review and meta-analysis of cohort studies and experimental sleep deprivation

    Biological Psychiatry

    (2016)
  • A. Jyoti et al.

    Progressive age-related changes in sleep and EEG profiles in the PLB1Triple mouse model of Alzheimer's disease

    Neurobiology of Aging

    (2015)
  • G.C. Kincheski et al.

    Chronic sleep restriction promotes brain inflammation and synapse loss, and potentiates memory impairment induced by amyloid-beta oligomers in mice

    Brain, Behavior, and Immunity

    (2017)
  • J.C. Kreutzmann et al.

    Sleep deprivation and hippocampal vulnerability: Changes in neuronal plasticity, neurogenesis and cognitive function

    Neuroscience

    (2015)
  • R. Lalonde et al.

    Exploratory activity and spatial learning in 12-month-old APP(695)SWE/co+PS1/DeltaE9 mice with amyloid plaques

    Neuroscience Letters

    (2005)
  • R.B. Machado et al.

    Sleep deprivation induced by the modified multiple platform technique: Quantification of sleep loss and recovery

    Brain Research

    (2004)
  • L. Peter-Derex et al.

    Sleep and Alzheimer's disease

    Sleep Medicine Reviews

    (2015)
  • D. Petit et al.

    Sleep and quantitative EEG in neurodegenerative disorders

    Journal of Psychosomatic Research

    (2004)
  • B. Platt et al.

    The cholinergic system, EEG and sleep

    Behavioural Brain Research

    (2011)
  • G. Rammes et al.

    Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of beta-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices

    Neuropharmacology

    (2011)
  • S.M. Rothman et al.

    Chronic mild sleep restriction accentuates contextual memory impairments, and accumulations of cortical Abeta and pTau in a mouse model of Alzheimer's disease

    Brain Research

    (2013)
  • A. Satlin et al.

    Circadian locomotor activity and core-body temperature rhythms in Alzheimer's disease

    Neurobiology of Aging

    (1995)
  • K. Schindowski et al.

    Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits

    American Journal of Pathology

    (2006)
  • R. Schliebs et al.

    The cholinergic system in aging and neuronal degeneration

    Behavioural Brain Research

    (2011)
  • M.D. Schwartz et al.

    The neurobiology of sleep and wakefulness

    The Psychiatric Clinics of North America

    (2015)
  • L. Scott et al.

    Age-dependent disruption in hippocampal theta oscillation in amyloid-beta overproducing transgenic mice

    Neurobiology of Aging

    (2012)
  • M. Sethi et al.

    Increased fragmentation of sleep-wake cycles in the 5XFAD mouse model of Alzheimer's disease

    Neuroscience

    (2015)
  • R.A. Sperling et al.

    Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

    Alzheimer's & Dementia

    (2011)
  • A.R. Adamantidis et al.

    Neural substrates of awakening probed with optogenetic control of hypocretin neurons

    Nature

    (2007)
  • B. Bie et al.

    Epigenetic suppression of neuroligin 1 underlies amyloid-induced memory deficiency

    Nature Neuroscience

    (2014)
  • D.L. Bliwise

    Sleep disorders in Alzheimer's disease and other dementias

    Clinical Cornerstone

    (2004)
  • K. Bordji et al.

    Activation of extrasynaptic, but not synaptic, NMDA receptors modifies amyloid precursor protein expression pattern and increases amyloid-ss production

    Journal of Neuroscience

    (2010)
  • R. Boyce et al.

    Causal evidence for the role of REM sleep theta rhythm in contextual memory consolidation

    Science

    (2016)
  • H. Braak et al.

    Neuropathological stageing of Alzheimer-related changes

    Acta Neuropatholica

    (1991)
  • J. Brouillette

    The effects of soluble Abeta oligomers on neurodegeneration in Alzheimer's disease

    Current Pharmaceutical Design

    (2014)
  • E.C. Budreck et al.

    Neuroligin-1 controls synaptic abundance of NMDA-type glutamate receptors through extracellular coupling

    Proceedings of the National Academy of Sciences of the United States of America

    (2013)
  • J. Carrier et al.

    Sleep and morningness-eveningness in the 'middle' years of life (20–59 y)

    Journal of Sleep Research

    (1997)
  • Q. Chen et al.

    Association between ARNTL (BMAL1) rs2278749 polymorphism T >C and susceptibility to Alzheimer disease in a Chinese population

    Genetics and Molecular Research

    (2015)
  • J.M. Clinton et al.

    Biochemical regulation of sleep and sleep biomarkers

    Journal of Clinical Sleep Medicine

    (2011)
  • J. Colby-Milley et al.

    Sleep-wake cycle dysfunction in the TgCRND8 mouse model of Alzheimer's disease: From early to advanced pathological stages

    PLoS One

    (2015)
  • B. Deleglise et al.

    beta-amyloid induces a dying-back process and remote trans-synaptic alterations in a microfluidic-based reconstructed neuronal network

    Acta Neuropathologica Commununications

    (2014)
  • L. Descarries et al.

    The acetylcholine innervation of cerebral cortex: New data on its normal development and its fate in the hAPP(SW, IND) mouse model of Alzheimer's disease

    Journal Neural Transmission

    (2005)
  • S. Diekelmann et al.

    The memory function of sleep

    Nature Reviews Neuroscience

    (2010)
  • M.C. Dinamarca et al.

    The synaptic protein neuroligin-1 interacts with the amyloid beta-peptide. Is there a role in Alzheimer's disease?

    Biochemistry

    (2011)
  • G.A. Elder et al.

    Transgenic mouse models of Alzheimer's disease

    Mount Sinai Journal of Medicine

    (2010)
  • J. El Helou et al.

    Neuroligin-1 links neuronal activity to sleep-wake regulation

    Proceedings of the National Academy of Sciences of the United States of America

    (2013)
  • Cited by (14)

    • Disrupted prefrontal neuronal oscillations and morphology induced by sleep deprivation in young APP/PS1 transgenic AD mice

      2021, Brain Research Bulletin
      Citation Excerpt :

      Sleep disturbance is a common and debilitating symptom of Alzheimer's disease (AD), and recent evidence has highlighted a bidirectional relationship between sleep and AD (Dufort-Gervais et al., 2019; Ju et al., 2014; Tabuchi et al., 2015a; Wang and Holtzman, 2020).

    • Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: A potential therapeutic molecule for Alzheimer's disease

      2020, Biomedicine and Pharmacotherapy
      Citation Excerpt :

      During sleep, extracellular Aβ is removed through the glymphatic pathway twice as fast as during awake periods [267]. The mechanisms linking Aβ pathology and sleep disorder have recently been demonstrated as a bidirectional relationship [268,269]. Circadian rhythm disruption is not only the consequence of Aβ-induced neurodegeneration, but also the reason for the pathogenesis of AD.

    • Orexins role in neurodegenerative diseases: From pathogenesis to treatment

      2020, Pharmacology Biochemistry and Behavior
      Citation Excerpt :

      In addition, it reduced the clearance of autophagosomes through disruption of the autophagosome-lysosome fusion process, resulting in impaired Aβ degradation in BV2 cells (An et al., 2017). Furthermore, there is an increasing level of evidence showing bidirectional association between Aβ and orexin expression (Dufort-Gervais et al., 2018). As explained earlier, over activity of orexins is associated with abnormality in sleep patterns and Aβ level.

    • Alzheimer's disease pathogenesis: The role of disturbed sleep in attenuated brain plasticity and neurodegenerative processes

      2019, Cellular Signalling
      Citation Excerpt :

      For example, amyloid plaques and tau tangles are also commonly found in brain regions critical for the regulation and modulation of the sleep-wake cycle, including locus coeruleus, hypothalamus, and the cortical layers [20]. Importantly, the connection between AD pathogenesis at the level of Aβ and the disruption of the sleep-wake cycle is thought to be reciprocal [19]. Indeed, even a single night of sleep deprivation elevates Aβ levels in the human brain [21].

    View all citing articles on Scopus
    View full text